Investment Pitch

Name: FSD Pharma signs binding LOI to acquire NASDAQ-listed Therapix Biosciences
Uploaded: 05/11/2022 22:48:54
Duration: 00:05:04
Description: Therapix is currently repurposing an FDA-approved cannabinoid for the treatment of central nervous system disorders, sleep disorders, pain management, mild cognitive impairment, traumatic brain injury and infectious diseases.

FSD Pharma signs binding LOI to acquire NASDAQ-listed Therapix Biosciences

fullscreen